197 related articles for article (PubMed ID: 2139159)
1. Influence of erythropoietin treatment on plasma renin activity, aldosterone, vasopressin and atrial natriuretic peptide in haemodialyzed patients.
Kokot F; Wiecek A; Grzeszczak W; Klin M
Miner Electrolyte Metab; 1990; 16(1):25-9. PubMed ID: 2139159
[TBL] [Abstract][Full Text] [Related]
2. Influence of long-term erythropoietin therapy on endocrine abnormalities in haemodialyzed patients.
Kokot F; Wiecek A; Schmidt-Gayk H; Marcinkowski W; Nieszporek T; Rudka R; Trembecki J
Przegl Lek; 1992; 49(1-2):43-9. PubMed ID: 1455006
[TBL] [Abstract][Full Text] [Related]
3. Water immersion-induced alterations of plasma atrial natriuretic peptide level and its relationship to the renin-angiotensin-aldosterone system and vasopressin secretion in acute and chronic renal failure.
Kokot F; Grzeszczak W; Zukowska-Szczechowska E; Wiecek A
Clin Nephrol; 1989 May; 31(5):247-52. PubMed ID: 2525441
[TBL] [Abstract][Full Text] [Related]
4. Alterations of vasoconstrictor and sodium-regulating hormone systems in vascularly decompensated liver cirrhosis.
Tulassay T; Tulassay Z; Büki B; Szathmári M; Rascher W
Acta Med Hung; 1988; 45(1):73-81. PubMed ID: 2970621
[TBL] [Abstract][Full Text] [Related]
5. [Does long-term human recombinant erythropoietin (rHuEPO) influence secretion of hormones regulating volume and pressure of arterial blood?].
Rudka R; Kokot F; Wiecek A; Marcinkowski W; Trembecki J
Pol Arch Med Wewn; 1994 Aug; 92(2):154-61. PubMed ID: 7800584
[TBL] [Abstract][Full Text] [Related]
6. Do opioid receptors participate in the regulation of atrial natriuretic peptide (ANP) secretion in hypertensive patients?
Widera W; Kokot F; Wiecek A
Clin Nephrol; 1992 Oct; 38(4):209-13. PubMed ID: 1330391
[TBL] [Abstract][Full Text] [Related]
7. Fluid homeostasis after heart transplantation: the role of cardiac denervation.
Braith RW; Mills RM; Wilcox CS; Convertino VA; Davis GL; Limacher MC; Wood CE
J Heart Lung Transplant; 1996 Sep; 15(9):872-80. PubMed ID: 8889982
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels of atrial natriuretic peptide and endocrine markers of volume depletion in patients with obstructive jaundice.
Gallardo JM; Padillo J; Martín-Malo A; Miño G; Pera C; Sitges-Serra A
Br J Surg; 1998 Jan; 85(1):28-31. PubMed ID: 9462378
[TBL] [Abstract][Full Text] [Related]
9. Endocrine response to plasma volume expansion during the early postoperative period in heart transplant recipients.
Mertes PM; de Talancé N; Carteaux JP; Pinelli G; Dopff C; Burtin P; Villemot JP; Burlet C; Boulangé M
J Heart Lung Transplant; 1993; 12(6 Pt 1):1001-8. PubMed ID: 8312300
[TBL] [Abstract][Full Text] [Related]
10. Plasma atrial natriuretic peptide, plasma renin activity and aldosterone during treatment of hyperthyroidism due to Graves' disease.
Shigematsu S; Iwasaki T; Aizawa T; Ishihara M; Shinoda T; Yamada T; Sato A; Takemura Y
Horm Metab Res; 1989 Sep; 21(9):514-8. PubMed ID: 2531114
[TBL] [Abstract][Full Text] [Related]
11. Prolonged exercise following diuretic-induced hypohydration effects on fluid and electrolyte hormones.
Roy BD; Green HJ; Burnett M
Horm Metab Res; 2001 Sep; 33(9):540-7. PubMed ID: 11561214
[TBL] [Abstract][Full Text] [Related]
12. Renal response to central volume expansion induced by water immersion (WI) in heart transplant patients.
Kokot F; Religa Z; Pasyk S; Wiecek A; Frycz J; Grzeszczak W; Bochenek A; Duława J
Acta Med Pol; 1989; 30(3-4):111-9. PubMed ID: 2535269
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide in patients with decompensated hepatic cirrhosis.
Tulassay T; Tulassay Z; Rascher W
Gastroenterol J; 1990; 50(3):140-3. PubMed ID: 2149634
[TBL] [Abstract][Full Text] [Related]
14. High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: indirect evidence of reduced natriuretic effectiveness of the peptide.
Trevisani F; Colantoni A; Sica G; Gasbarrini A; D'Intino PE; De Notariis S; De Jaso R; Barbieri A; Morselli A; Gasbarrini G
Hepatology; 1995 Jul; 22(1):132-7. PubMed ID: 7601404
[TBL] [Abstract][Full Text] [Related]
15. [The circadian rhythm of plasma vasoactive intestinal peptide, atrial natriuretic peptide, renin activity, aldosterone and cortisol in heart transplantation. The effects of immunosuppressive therapy].
Cugini P; Gasbarrone L; Lucia P; Cianetti A; Canova R; Di Palma L; Sepe FA; Pozzilli P; Scibilia G; Cioli AR
Cardiologia; 1992 Oct; 37(10):693-9. PubMed ID: 1296875
[TBL] [Abstract][Full Text] [Related]
16. Influence of hemodialysis on the plasma levels of the atrial natriuretic factor in chronic renal failure.
Larochelle P; Béroniade V; Gutkowska J; Cusson JR; Lécrivain A; du Souich P; Cantin M; Genest J
Clin Invest Med; 1987 Jul; 10(4):350-4. PubMed ID: 2958203
[TBL] [Abstract][Full Text] [Related]
17. [Response of vasoactive substance to blood pressure changes during hemodialysis in uremic patients].
Witkowicz J; Kokot F; Irzyniec T; Chudek J; Ficek R
Pol Arch Med Wewn; 1999 Sep; 102(3):763-71. PubMed ID: 10949883
[TBL] [Abstract][Full Text] [Related]
18. [Atrial natriuretic peptide, renin-aldosterone system and arterial pressure. Analysis by circadian rhythm measurement].
Colantonio D; Pasqualetti P; Casale R; Desiati P; Giandomenico G; Natali G
Minerva Cardioangiol; 1989; 37(7-8):319-22. PubMed ID: 2532714
[TBL] [Abstract][Full Text] [Related]
19. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
Burghardt W; Müller R; Diehl KL; Wernze H
Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163
[TBL] [Abstract][Full Text] [Related]
20. Effects of atrial natriuretic peptide at a low dose on water and electrolyte metabolism during general anesthesia.
Koda M; Sakamoto A; Ogawa R
J Clin Anesth; 2005 Feb; 17(1):3-7. PubMed ID: 15721722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
